-
公开(公告)号:US08349817B2
公开(公告)日:2013-01-08
申请号:US12644758
申请日:2009-12-22
IPC分类号: A61K31/4709 , A61K31/4365 , A61K31/616 , A61P3/10 , A61P9/00 , A61P9/10 , A61P11/06 , A61P29/00 , C07D401/12
CPC分类号: C07D215/20 , A61K31/10 , A61K31/4365 , A61K31/4709 , A61K31/60 , C07D401/12
摘要: This invention relates to novel compounds which are derivatives of the phosphodiesterase inhibitor, cilostazol and pharmaceutically acceptable salts thereof. This invention also provides pyrogen-free compositions comprising one or more compounds of the invention and the use of the disclosed compounds and compositions in methods of treating diseases and conditions that are treated by administration of a phosphodiesterase inhibitor, such as cilostazol. The invention also relates to the use of the disclosed compounds and compositions as reagents in analytical studies involving cilostazol.
摘要翻译: 本发明涉及作为磷酸二酯酶抑制剂西洛他唑及其药学上可接受的盐的衍生物的新化合物。 本发明还提供了包含一种或多种本发明化合物的无热原组合物,以及所公开的化合物和组合物在治疗通过施用磷酸二酯酶抑制剂如西洛他唑治疗的疾病和病症的方法中的用途。 本发明还涉及所公开的化合物和组合物在涉及西洛他唑的分析研究中作为试剂的用途。
-
公开(公告)号:US20100249079A1
公开(公告)日:2010-09-30
申请号:US12644758
申请日:2009-12-22
IPC分类号: A61K31/4709 , C07D401/12 , A61K31/616 , A61K31/4365 , A61P9/00 , A61P9/10 , A61P29/00 , A61P11/06 , A61P3/10
CPC分类号: C07D215/20 , A61K31/10 , A61K31/4365 , A61K31/4709 , A61K31/60 , C07D401/12
摘要: This invention relates to novel compounds which are derivatives of the phosphodiesterase inhibitor, cilostazol and pharmaceutically acceptable salts thereof. This invention also provides pyrogen-free compositions comprising one or more compounds of the invention and the use of the disclosed compounds and compositions in methods of treating diseases and conditions that are treated by administration of a phosphodiesterase inhibitor, such as cilostazol. The invention also relates to the use of the disclosed compounds and compositions as reagents in analytical studies involving cilostazol.
摘要翻译: 本发明涉及作为磷酸二酯酶抑制剂西洛他唑及其药学上可接受的盐的衍生物的新化合物。 本发明还提供了包含一种或多种本发明化合物的无热原组合物,以及所公开的化合物和组合物在治疗通过施用磷酸二酯酶抑制剂如西洛他唑治疗的疾病和病症的方法中的用途。 本发明还涉及所公开的化合物和组合物在涉及西洛他唑的分析研究中作为试剂的用途。
-
公开(公告)号:US08354557B2
公开(公告)日:2013-01-15
申请号:US12456507
申请日:2009-06-17
申请人: Julie F. Liu , Xuejun Tang , Scott L. Harbeson , Craig E. Masse
发明人: Julie F. Liu , Xuejun Tang , Scott L. Harbeson , Craig E. Masse
IPC分类号: C07C215/68
CPC分类号: C07D413/10 , A61K31/5377 , A61K45/06 , C07B2200/05 , C07C215/12 , C07D263/06 , C07D295/02 , C07D295/033 , C07D295/06 , C07D295/12 , C07D295/135 , C07D413/14
摘要: The present invention is directed to a process for preparing a 2,26,6-d4-morpholine derivative represented by Structural Formula (I): or a salt thereof.
摘要翻译: 本发明涉及一种制备由结构式(I)表示的2,26,6-d4-吗啉衍生物或其盐的方法。
-
公开(公告)号:US20100160247A1
公开(公告)日:2010-06-24
申请号:US12456507
申请日:2009-06-17
申请人: Julie F. Liu , Xuejun Tang , Scott L. Harbeson , Craig E. Masse
发明人: Julie F. Liu , Xuejun Tang , Scott L. Harbeson , Craig E. Masse
IPC分类号: A61K31/5377 , C07C215/68 , C07D265/30 , C07D413/10 , A61K31/7036 , A61K31/397 , A61P31/06 , A61P31/04 , A61P31/10 , A61K31/546 , A61K31/5383
CPC分类号: C07D413/10 , A61K31/5377 , A61K45/06 , C07B2200/05 , C07C215/12 , C07D263/06 , C07D295/02 , C07D295/033 , C07D295/06 , C07D295/12 , C07D295/135 , C07D413/14
摘要: The present invention is directed to a process for preparing a 2,26,6-d4-morpholine derivative represented by Structural Formula (I): or a salt thereof.
摘要翻译: 本发明涉及一种制备由结构式(I)表示的2,26,6-d4-吗啉衍生物或其盐的方法。
-
公开(公告)号:US20130281456A1
公开(公告)日:2013-10-24
申请号:US13678093
申请日:2012-11-15
申请人: Julie F. Liu , Xuejun Tang , Scott L. Harbeson , Craig E. Masse
发明人: Julie F. Liu , Xuejun Tang , Scott L. Harbeson , Craig E. Masse
IPC分类号: C07D263/06
CPC分类号: C07D413/10 , A61K31/5377 , A61K45/06 , C07B2200/05 , C07C215/12 , C07D263/06 , C07D295/02 , C07D295/033 , C07D295/06 , C07D295/12 , C07D295/135 , C07D413/14
摘要: The present invention is directed to a process for preparing a 2,26,6-d4-morpholine derivative represented by Structural Formula (I): or a salt thereof.
-
公开(公告)号:US20130005742A1
公开(公告)日:2013-01-03
申请号:US13388806
申请日:2010-08-06
申请人: Scott L. Harbeson , Craig E. Masse , Julie F. Liu
发明人: Scott L. Harbeson , Craig E. Masse , Julie F. Liu
IPC分类号: A61K31/4965 , A61P7/02 , A61P9/00 , A61P9/10 , C07D241/20 , A61P9/12
CPC分类号: A61K31/50 , A61K45/06 , C07D241/20 , A61K2300/00
摘要: This invention relates to novel substituted diphenylpyrazines and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a PGI2 receptor agonist.
摘要翻译: 本发明涉及新型取代的二苯基吡嗪及其药学上可接受的盐。 本发明还提供包含本发明化合物的组合物以及这些组合物在治疗通过施用PGI 2受体激动剂有益治疗的疾病和病症的方法中的用途。
-
公开(公告)号:US20100305173A1
公开(公告)日:2010-12-02
申请号:US12771551
申请日:2010-04-30
申请人: Scott L. Harbeson , Roger D. Tung , Julie F. Liu , Craig E. Masse
发明人: Scott L. Harbeson , Roger D. Tung , Julie F. Liu , Craig E. Masse
IPC分类号: A61K31/428 , C07D493/04 , A61K31/34 , A61K31/427 , A61P31/18 , A61P33/06 , A61K31/36
CPC分类号: C07D493/04
摘要: This invention relates to novel hydroxyethylamino sulfonamides, their derivatives, pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a compound with the ability to act as an HIV (human immunodeficiency virus) protease inhibitor.
摘要翻译: 本发明涉及新的羟乙基氨基磺酰胺,其衍生物,其药学上可接受的盐。 本发明还提供了包含本发明化合物的组合物和这些组合物在治疗通过施用具有作为HIV(人类免疫缺陷病毒)蛋白酶抑制剂的能力的化合物有益治疗的疾病和病症的方法中的用途。
-
公开(公告)号:US20090042842A1
公开(公告)日:2009-02-12
申请号:US12150107
申请日:2008-04-24
申请人: Julie F. Liu , Rose A. Persichetti
发明人: Julie F. Liu , Rose A. Persichetti
IPC分类号: A61K31/60 , C07D215/20 , A61K31/4365 , A61P3/10 , A61P29/00 , A61P9/00 , A61K31/47
CPC分类号: C07D401/12
摘要: This invention relates to novel compounds which are derivatives of the phosphodiesterase inhibitor, cilostazol and pharmaceutically acceptable salts thereof. This invention also provides pyrogen-free compositions comprising one or more compounds of the invention and the use of the disclosed compounds and compositions in methods of treating diseases and conditions that are treated by administration of an phosphodiesterase inhibitor, such as cilostazol. The invention also relates to the use of the disclosed compounds and compositions as reagents in analytical studies involving cilostazol.
摘要翻译: 本发明涉及作为磷酸二酯酶抑制剂西洛他唑及其药学上可接受的盐的衍生物的新化合物。 本发明还提供了包含一种或多种本发明化合物的无热原组合物,以及所公开的化合物和组合物在治疗通过施用磷酸二酯酶抑制剂如西洛他唑治疗的疾病和病症的方法中的用途。 本发明还涉及所公开的化合物和组合物在涉及西洛他唑的分析研究中作为试剂的用途。
-
公开(公告)号:US08357674B2
公开(公告)日:2013-01-22
申请号:US13538952
申请日:2012-06-29
申请人: Julie F. Liu , Rose A. Persichetti
发明人: Julie F. Liu , Rose A. Persichetti
IPC分类号: A61K31/4709 , A61K31/616 , A61P3/10 , A61P9/00 , A61P3/04 , A61P7/02 , A61P1/04 , A61P11/06 , A61P15/00 , A61P9/10 , C07D401/12
CPC分类号: C07D401/12
摘要: This invention relates to novel compounds which are derivatives of the phosphodiesterase inhibitor, cilostazol and pharmaceutically acceptable salts thereof. This invention also provides pyrogen-free compositions comprising one or more compounds of the invention and the use of the disclosed compounds and compositions in methods of treating diseases and conditions that are treated by administration of an phosphodiesterase inhibitor, such as cilostazol. The invention also relates to the use of the disclosed compounds and compositions as reagents in analytical studies involving cilostazol.
-
公开(公告)号:US20120264721A1
公开(公告)日:2012-10-18
申请号:US13538952
申请日:2012-06-29
申请人: Julie F. Liu , Rose A. Persichetti
发明人: Julie F. Liu , Rose A. Persichetti
IPC分类号: A61K31/4709 , A61K31/616 , A61P3/10 , A61P9/00 , A61P3/04 , A61P7/02 , A61P1/04 , A61P11/06 , A61P15/00 , C07D401/12 , A61P9/10
CPC分类号: C07D401/12
摘要: This invention relates to novel compounds which are derivatives of the phosphodiesterase inhibitor, cilostazol and pharmaceutically acceptable salts thereof. This invention also provides pyrogen-free compositions comprising one or more compounds of the invention and the use of the disclosed compounds and compositions in methods of treating diseases and conditions that are treated by administration of an phosphodiesterase inhibitor, such as cilostazol. The invention also relates to the use of the disclosed compounds and compositions as reagents in analytical studies involving cilostazol.
摘要翻译: 本发明涉及作为磷酸二酯酶抑制剂西洛他唑及其药学上可接受的盐的衍生物的新化合物。 本发明还提供了包含一种或多种本发明化合物的无热原组合物,以及所公开的化合物和组合物在治疗通过施用磷酸二酯酶抑制剂如西洛他唑治疗的疾病和病症的方法中的用途。 本发明还涉及所公开的化合物和组合物在涉及西洛他唑的分析研究中作为试剂的用途。
-
-
-
-
-
-
-
-
-